Endocrine Society

Announcing Our New 2026 President-Elect | Please join us in congratulating our newest leader! Joy Wu, MD, PhD, will assume the position at #ENDO2026: https://bit.ly/4sumHx1

Introducing the ExCEL Class of 2026 | The #ExCEL2026 program is excited to announce the class of 2026. Participants will build leadership skills and expand their network in comprehensive leadership training and mentorship: bit.ly/4jCA4r6

Congratulations to the FLARE Class of 2026 | Our #FLARE2026 program is excited to welcome the next class of participants. Recipients will participate in hands-on training in topics ranging from grantsmanship to lab management: bit.ly/4coX242

Today, we recognize and support #WorldObesityDay. As obesity rates climb globally, endocrinologists play a crucial role in diagnosis and treatment. Access our latest educational resources (bit.ly/3yV6Ihc) and view our priorities on obesity (bit.ly/36wGe7U). #endocrinology

Last Chance to Apply for Our Rare Endocrine Disease (RED) Fellows Program | The deadline for our RED Fellows Program has been extended to Friday, March 6. Apply today: bit.ly/4r5S7cD #endocrinology

ESAP 2026: Now Available | Endocrine Self-Assessment (ESAP) 2026 features 120 new, case-based questions developed for endocrinologists who want to sharpen clinical judgment and assess their knowledge with confidence. Order now: bit.ly/40JYQ0d #endocrinology

ENDO 2026 opens media registration Members of the media can now register to cover advances in hormone health and science at ENDO 2026, the Endocrine Society’s annual meeting. The meeting will take place June 13-16, in Chicago, Ill.

Media registration for #ENDO2026 is now open! Cover the latest breakthroughs in obesity, diabetes, reproductive health, endocrine‑disrupting chemicals, and more. #EndoSky
📍June 13–16, Chicago
📝 Details & registration: bit.ly/4qVvGGi

Beyond the Scale: What Else Glucagon-like Peptide-1 Receptor Agonists Can Do - Endocrine News In the United States, American Heart Month is observed in February to raise awareness about cardiovascular disease, the leading cause of death worldwide. To a similar end, Endocrine News focuses on a ...

Beyond the Scale: What Else Glucagon-like Peptide-1 Receptor Agonists Can Do | @endocrinenews.bsky.social focuses on a few recent journal studies that take a closer look at the impacts of incretin-based therapies in the setting of obesity and impaired cardiovascular health: https://bit.ly/46u0erf

Rare Endocrine Disease Fellows Program Developed in partnership with the National Organization for Rare Disorders (NORD), this program addresses critical gaps in awareness, diagnosis, and care of rare endocrine diseases, equipping fellows ...

#RareDiseaseDay is the perfect time to nominate or submit a self-nomination for our RED Fellows Program. Participate in an in-person workshop and receive a travel reimbursement. The application deadline is Monday, March 2: https://bit.ly/4r5S7cD @rarediseaseday.bsky.social

During #RareDiseaseDay, explore our latest resources on rare disease diagnoses and treatments featured in our Thematic Issue (https://bit.ly/3NQ9RtQ), Center for Learning (https://bit.ly/3APhFR0), and ENDO 2025 Session Recordings (https://bit.ly/47FiT4W). @rarediseaseday.bsky.social

Help Us Thank Congress for Funding Research | If you receive NIH funding for your research, we are encouraging you to thank your Representative and Senators for the work they did to provide increased funding and protections for the agency. Take action now: https://bit.ly/46nxArW

One Week Left to Submit Your Best Microscopy to Our Endocrine Images Art Competition | The winner will have their artwork displayed at ENDO and receive complimentary registration to either #ENDO2026 or #ENDO2027. The deadline is Friday, March 6: bit.ly/3htQ3ct

Endocrine-Disrupting Chemicals

A Pew Charitable Trusts survey found more than 70% of US adults are concerned about harmful chemicals in food and drinking water. Learn more about endocrine-disrupting chemicals, where they are found, and the threat to public health: https://bit.ly/2simKTL #EDCs #EndoSky

Elevate your clinical expertise with our latest on-demand education in the Center for Learning. Expiring courses explore interconnectivity of T2D, cardiovascular disease, and chronic kidney disease (bit.ly/4cqKEQQ) to mastering the latest advancements #diabetes screening (bit.ly/40hhzA6). #EndoSky

COVID-19 Infection Linked to Relapse of Rare Endocrine Disorder After 19 Years - Endocrine News A rare case study published in JCEM Case Reports details the first known instance of a decades-dormant hormonal disorder, Cyclic Cushing Syndrome (CS), relapsing after a patient contracted COVID-19 an...

A rare case study published in #JCEMCR details the first known instance of a decades-dormant hormonal disorder, Cyclic #Cushing Syndrome, relapsing after a patient contracted #COVID19 and received standard glucocorticoid treatment. #EndoSky

endocrinenews.endocrine.org/covid-19-inf...

New Directions in Thyroid Care: Minimizing Risk, Maximizing Choice - Endocrine News From how radioiodine therapy for Graves’ disease impacts cancer occurrence and the potential usefulness of pharmacologic treatment for benign thyroid nodules to how a minimally invasive procedure coul...

As #Thyroid Awareness Month begins, three studies in #JCEM offer new insights into the management of common thyroid conditions, from the promise of noninvasive drug therapies to reassurance about the safety of established treatments. #EndoSky

endocrinenews.endocrine.org/new-directio...

Endocrine Neoplasia and Cancer

Explore our endocrine neoplasia and cancer topical page (https://bit.ly/349rR7Y). View resources including our thematic issue that highlights the latest research in the field (https://bit.ly/3NQ9RtQ). #endocrinology #cancer

Nominate yourself for our Rare Endocrine Disease (RED) Fellows Program. Accepted US fellows will receive travel reimbursement for an immersive in-person workshop with leading experts, April 17–18, and access to on-demand courses: bit.ly/4r5S7cD #endocrinology #EndoSky

Severe Refractory Calcitriol-Mediated Hypercalcemia in Diffuse Large B-Cell Lymphoma Treated With Hemodialysis Abstract. Hypercalcemia of malignancy is a recognized complication of diffuse large B-cell lymphoma (DLBCL) and is associated with decreased survival time

Severe Refractory Calcitriol-Mediated Hypercalcemia in Diffuse Large B-Cell Lymphoma Treated With Hemodialysis. Read more in #JCEM Case Reports: bit.ly/4kJwigJ #nonHodgkinLymphoma #calcitriol #HypercalcemiaofMalignancy @endocrinesociety.bsky.social

2025 Researchers Roundtable: Discussing Endocrine Science with the 2025 Early Investigator Award Winners - Endocrine News Every year the Endocrine Society recognizes endocrinologists who are in the early stages of their research careers with the Early Investigator Awards. Endocrine News spoke to the five award recipients...

We spoke to the five Early Investigator Award recipients from around the world to find out more about their award-winning research, the award’s potential impact, as well as the biggest challenges facing them today. #endocrinology #EndoSky

endocrinenews.endocrine.org/2025-researc...

Anna Gloyn Wins 2026 Transatlantic Alliance Award in Endocrinology  - Endocrine News The Endocrine Society and The European Society of Endocrinology (ESE) are delighted to announce Anna Gloyn, DPhil, FMedSci, as the winner of the fifth annual Transatlantic Alliance Award.  The Transat...

The endocrinesociety.bsky.social and the esendocrinology.bsky.social are delighted to announce Anna Gloyn, DPhil, FMedSci, as the winner of the fifth annual Transatlantic Alliance Award. #EndoSky

endocrinenews.endocrine.org/anna-gloyn-w...

Markedly Melanin-Pigmented Paraganglioma Associated With Decreased Dopa-Decarboxylase Expression Abstract. A 49-year-old woman undergoing evaluation for sigmoid colon cancer was incidentally found to have a 56-mm retroperitoneal tumor. Although asympto

Markedly Melanin-Pigmented Paraganglioma Associated With Decreased Dopa-Decarboxylase Expression. Read more in #JCEM Case Reports: bit.ly/4j30oLt #PigmentedTumor #Paraganglioma #Pheochromocytoma @endocrinesociety.bsky.social

Lean Body Mass as a Predictor of Levothyroxine Requirement in Primary Hypothyroidism as Compared to Actual Body Weight AbstractContext. Levothyroxine (LT4) therapy for hypothyroidism is traditionally dosed at 1.6 μg/kg of actual body weight (ABW). However, ABW-based dosing

Lean Body Mass as a Predictor of Levothyroxine Requirement in Primary Hypothyroidism as Compared to Actual Body Weight. Read more in #JES: bit.ly/48UhExB #PrimaryHypothyroidism #Levothyroxine #LeanBodyMass @endocrinesociety.bsky.social

Benefit from #ENDO2026 by gaining insights from world-class faculty, networking with industry leaders, and exploring over 2,500 abstracts in the ENDOExpo. Early registration rates end on Tuesday, March 24: bit.ly/4awLVUd #EndoSky #endocrinology

Inaugural Obesity Summit in India | Over 600 attendees (clinicians, researchers, and multidisciplinary teams) shaped the next decade of obesity management along with expert faculty who are Endocrine Society members. Access our #obesity resources: bit.ly/3yV6Ihc

Endocrinologists Urged to Master Birth Control as Key Tool for Hormonal Health - Endocrine News A critical gap in medical knowledge is severely limiting care for patients with hormonal disorders: A new review in Endocrine Reviews delivers a wake-up call to endocrinologists, asserting that these ...

A recent review in #EndocrineReviews delivers a wake-up call to #endocrinologists, asserting that these specialists must drastically expand their training in contraception. #EndoSky

endocrinenews.endocrine.org/endocrinolog...

Outcomes and Therapeutic Strategies for Head-and-neck Paragangliomas Associated With Succinate Dehydrogenase Mutations. Read more in #JCEM: bit.ly/48Rs0yg #Paraganglioma #Radiotherapy #TumoralProgression @endocrinesociety.bsky.social

What are your favorite articles in the current issue of @endocrinenews.bsky.social? Our cover story discusses GLP-1RAs. Our features highlight the positive and negative unintended impacts of GLP-1RAs and remember Joel Habener, MD: https://bit.ly/4pGushs

Endocrine Feedback Loop Podcast | Listen to Andrew Crawford, MD, and Giuseppe Barbesino, MD, discuss a recent #JCEM article (https://bit.ly/4kImBz4) on the impact of low doses of methimazole to predict or even cause a sustained remission in Graves’ disease: https://bit.ly/EFL070

Genomic Crosstalk Between Nuclear Receptors in Hormone-dependent Cancers Abstract. Nuclear receptors (NRs) orchestrate transcriptional programs that regulate cell fate decisions, and when these processes are disrupted, they can

Genomic Crosstalk Between Nuclear Receptors in Hormone-dependent Cancers. Read more in #Endocrinology: bit.ly/4aiWdJ5 #NuclearReceptors #Cistrome #Transcriptome @endocrinesociety.bsky.social